Understanding how B lymphocytes contribute to autoimmune diseases like rheumatoid arthritis
B Lymphocytes in Autoimmune Disease
This study is looking at how certain immune cells called B lymphocytes might contribute to rheumatoid arthritis by producing harmful antibodies, and it’s exploring how a protein called BTK affects this process, which could help us understand more about the disease and find better ways to manage it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Louis VA Medical Center NIH-funded |
| Lab location | 1 site (St. Louis, UNITED STATES) |
| Project ID | NIH-11109720 on NIH RePORTER |
What this research studies
This research investigates the role of B lymphocytes, a type of immune cell, in the development of rheumatoid arthritis (RA). The team is exploring how these cells produce autoantibodies that lead to joint damage and how a specific protein, Bruton’s tyrosine kinase (BTK), influences this process. By studying mice with altered BTK signaling, researchers aim to uncover the relationship between B cells, the gut microbiome, and autoimmune responses. This work could reveal new insights into how immune regulation can affect the onset and progression of RA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rheumatoid arthritis or those at risk of developing autoimmune diseases.
Not a fit: Patients with autoimmune conditions unrelated to B lymphocyte activity or those without rheumatoid arthritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating rheumatoid arthritis.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune cells in autoimmune diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
St. Louis, UNITED STATES
- St. Louis VA Medical Center — St. Louis, United States (Active)
Researchers
- Principal investigator: Kendall, Peggy L — St. Louis VA Medical Center
- Study coordinator: Kendall, Peggy L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.